White, Mike – Trademark Portfolio
Entity Type: 01
White, Mike has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as SEPTIC RX. Filings span 5 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 37 (Building & Construction). This trademark owner is based in Simi Valley, CA.
5775 E. Los Angeles Ave. Suite #117
Simi Valley, CA 93063
Showing of trademarks Trademarks
Trademark Classifications
White, Mike's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Insurance; financial affairs; monetary affairs; real estate affairs
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does White, Mike have?
White, Mike has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does White, Mike file in?
White, Mike files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 1 (Chemicals), Class 36 (Insurance & Financial), Class 28 (Toys & Sporting Goods). Class 35 covers advertising; business management; business administration; office functions.
What are White, Mike's most well-known trademarks?
White, Mike's registered trademark portfolio includes well-known marks such as SEPTIC RX. These are among 2 currently registered trademarks in the portfolio.
What is White, Mike's trademark registration success rate?
White, Mike has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.